Rebound Thrombocytosis after Induction Chemotherapy is a Strong Biomarker for Favorable Outcome in AML Patients

Whereas the molecular events underlying acute myeloid leukemia (AML) are increasingly identified, dynamics of hematologic recovery following induction chemotherapy remain mysterious. Platelet recovery may vary between incomplete and excess recovery among patients achieving remission. We analyzed pla...

Descripción completa

Detalles Bibliográficos
Autores principales: Schnell, Bianca R., Seipel, Katja, Bacher, Ulrike, Jeker, Barbara, Mueller, Beatrice U., Banz, Yara, Novak, Urban, Pabst, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746035/
https://www.ncbi.nlm.nih.gov/pubmed/31723819
http://dx.doi.org/10.1097/HS9.0000000000000180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746035/
https://www.ncbi.nlm.nih.gov/pubmed/31723819
http://dx.doi.org/10.1097/HS9.0000000000000180

Ejemplares similares